Comment on, 177Lu-PSMA-617 in metastatic, castration-resistant prostate cancer"

被引：0
作者：
Radtke, Jan Philipp [1 ,2 ]
Albers, Peter [3 ]
Giesel, Frederik Lars [4 ]
机构：
[1] Heinrich Heine Univ Dusseldorf, Univ Klinikum Dusseldorf, Klin Urol, Dusseldorf, Germany
[2] Deutsch Krebsforschungszentrum, Abt Radiol, Heidelberg, Germany
[3] Univ Klinikum Dusseldorf, Klin Urol, Dusseldorf, Germany
[4] Univ Dusseldorf, Klin Nukl Med, Nukl Med, Dusseldorf, Germany
来源：
AKTUELLE UROLOGIE | 2022年 / 53卷 / 02期
关键词：
THERAPY;
D O I：
10.1055/a-1707-6928
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 11 条
[1]   Health-related quality of life (HRQoL), pain and safety outcomes in the phase III VISION study of 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer [J].
Fizazi, K. ;
Herrmann, K. ;
Krause, B. J. ;
Rahbar, K. ;
Chi, K. N. ;
Morris, M. J. ;
Sartor, O. ;
Tagawa, S. T. ;
Kendi, A. T. ;
Vogelzang, N. J. ;
Calais, J. ;
Nagarajah, J. ;
Wei, X. X. ;
Koshkin, V. S. ;
Beauregard, J-M. ;
Chang, B. ;
DeSilvio, M. ;
Messmann, R. A. ;
de Bono, J. .
ANNALS OF ONCOLOGY, 2021, 32 :S627-S628
[2]   Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study [J].
Gafita, Andrei ;
Calais, Jeremie ;
Grogan, Tristan R. ;
Hadaschik, Boris ;
Wang, Hui ;
Weber, Manuel ;
Sandhu, Shahneen ;
Kratochwil, Clemens ;
Esfandiari, Rouzbeh ;
Tauber, Robert ;
Zeldin, Anna ;
Rathke, Hendrik ;
Armstrong, Wesley R. ;
Robertson, Andrew ;
Thin, Pan ;
D'Alessandria, Calogero ;
Rettig, Matthew B. ;
Delpassand, Ebrahim S. ;
Haberkorn, Uwe ;
Elashoff, David ;
Herrmann, Ken ;
Czernin, Johannes ;
Hofman, Michael S. ;
Fendler, Wolfgang P. ;
Eiber, Matthias .
LANCET ONCOLOGY, 2021, 22 (08) :1115-1125
[3]   Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019 [J].
Gillessena, Silke ;
Attard, Gerhardt ;
Beer, Tomasz M. ;
Beltran, Himisha ;
Bjartell, Anders ;
Bossi, Alberto ;
Briganti, Alberto ;
Bristow, Rob G. ;
Chi, Kim N. ;
Clarke, Noel ;
Davis, Ian D. ;
de Bono, Johann ;
Drake, Charles G. ;
Duran, Ignacio ;
Eeles, Ros ;
Efstathiou, Eleni ;
Evans, Christopher P. ;
Fanti, Stefano ;
Feng, Felix Y. ;
Fizazi, Karim ;
Frydenberg, Mark ;
Gleave, Martin ;
Halabi, Susan ;
Heidenreich, Axel ;
Heinrich, Daniel ;
Higano, Celestia S. ;
Hofman, Michael S. ;
Hussain, Maha ;
James, Nicolas ;
Kanesvaran, Ravindran ;
Kantoff, Philip ;
Khauli, Raja B. ;
Leibowitz, Raya ;
Logothetis, Chris ;
Maluf, Fernando ;
Millman, Robin ;
Morgans, Alicia K. ;
Morris, Michael J. ;
Mottet, Nicolas ;
Mrabti, Hind ;
Murphy, Declan G. ;
Murthy, Vedang ;
Oh, William K. ;
Ost, Piet ;
OSullivan, Joe M. ;
Padhani, Anwar R. ;
Parker, Chris ;
Poon, Darren M. C. ;
Pritchard, Colin C. ;
Reiter, Robert E. .
EUROPEAN UROLOGY, 2020, 77 (04) :508-547
[4]   Re: Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer [J].
Hadaschik, Boris ;
Herrmann, Ken .
EUROPEAN UROLOGY, 2021, 80 (04) :520-521
[5]   [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial [J].
Hofman, Michael S. ;
Emmett, Louise ;
Sandhu, Shahneen ;
Iravani, Amir ;
Joshua, Anthony M. ;
Goh, Jeffrey C. ;
Pattison, David A. ;
Tan, Thean Hsiang ;
Kirkwood, Ian D. ;
Ng, Siobhan ;
Francis, Roslyn J. ;
Gedye, Craig ;
Rutherford, Natalie K. ;
Weickhardt, Andrew ;
Scott, Andrew M. ;
Lee, Sze-Ting ;
Kwan, Edmond M. ;
Azad, Arun A. ;
Ramdave, Shakher ;
Redfern, Andrew D. ;
Macdonald, William ;
Guminski, Alex ;
Hsiao, Edward ;
Chua, Wei ;
Lin, Peter ;
Zhang, Alison Y. ;
McJannett, Margaret M. ;
Stockler, Martin R. ;
Violet, John A. ;
Williams, Scott G. ;
Martin, Andrew J. ;
Davis, Ian D. .
LANCET, 2021, 397 (10276) :797-804
[6]   [177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study [J].
Hofman, Michael S. ;
Violet, John ;
Hicks, Rodney J. ;
Ferdinandus, Justin ;
Thang, Sue Ping ;
Akhurst, Tim ;
Iravani, Amir ;
Kong, Grace ;
Kumar, Aravind Ravi ;
Murphy, Declan G. ;
Eu, Peter ;
Jackson, Price ;
Scalzo, Mark ;
Williams, Scott G. ;
Sandhu, Shahneen .
LANCET ONCOLOGY, 2018, 19 (06) :825-833
[7]   PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617 [J].
Kratochwil, Clemens ;
Giesel, Frederik L. ;
Stefanova, Melsa ;
Benesova, Martina ;
Bronzel, Marcus ;
Afshar-Oromieh, Ali ;
Mier, Walter ;
Eder, Matthias ;
Kopka, Klaus ;
Haberkorn, Uwe .
JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (08) :1170-1176
[8]   [177Lu]Lutetium-labelled PSMA ligand-induced remission in a patient with metastatic prostate cancer [J].
Kratochwil, Clemens ;
Giesel, Frederik L. ;
Eder, Matthias ;
Afshar-Oromieh, Ali ;
Benesova, Martina ;
Mier, Walter ;
Kopka, Klaus ;
Haberkorn, Uwe .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (06) :987-988
[9]  
Mottet N, 2021, EAU GUIDELINES PROST
[10]   Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer [J].
Sartor, Oliver ;
de Bono, Johann ;
Chi, Kim N. ;
Fizazi, Karim ;
Herrmann, Ken ;
Rahbar, Kambiz ;
Tagawa, Scott T. ;
Nordquist, Luke T. ;
Vaishampayan, Nitin ;
El-Haddad, Ghassan ;
Park, Chandler H. ;
Beer, Tomasz M. ;
Armour, Alison ;
Perez-Contreras, Wendy J. ;
DeSilvio, Michelle ;
Kpamegan, Euloge ;
Gericke, Germo ;
Messmann, Richard A. ;
Morris, Michael J. ;
Krause, Bernd J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (12) :1091-1103
12